Pharma & Healthcare
Global Gabapentin Market Research Report 2025
- Nov 04, 25
- ID: 207575
- Pages: 98
- Figures: 98
- Views: 23
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gabapentin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gabapentin.
The Gabapentin market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gabapentin market comprehensively. Regional market sizes, concerning products by Type, by Application, by Therapeutic Indication and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gabapentin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Therapeutic Indication and by regions.
By Company
Pfizer
Depomed
TEVA
Viatris
Alvogen
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Glenmark
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike
Segment by Type
Capsule
Tablet
Injection
Segment by Therapeutic Indication
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others
Segment by Product Type
Branded Gabapentin
Generic Gabapentin
Segment by Application
Hospital
Retail Pharmacy
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gabapentin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gabapentin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Gabapentin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gabapentin.
The Gabapentin market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gabapentin market comprehensively. Regional market sizes, concerning products by Type, by Application, by Therapeutic Indication and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gabapentin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Therapeutic Indication and by regions.
By Company
Pfizer
Depomed
TEVA
Viatris
Alvogen
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Glenmark
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike
Segment by Type
Capsule
Tablet
Injection
Segment by Therapeutic Indication
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others
Segment by Product Type
Branded Gabapentin
Generic Gabapentin
Segment by Application
Hospital
Retail Pharmacy
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gabapentin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gabapentin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Gabapentin Market Overview
1.1 Product Definition
1.2 Gabapentin by Type
1.2.1 Global Gabapentin Market Value Comparison by Type (2024 VS 2031)
1.2.2 Capsule
1.2.3 Tablet
1.2.4 Injection
1.3 Gabapentin by Therapeutic Indication
1.3.1 Global Gabapentin Market Value Comparison by Therapeutic Indication: 2024 VS 2031
1.3.2 Epilepsy
1.3.3 Neuropathic Pain
1.3.4 Restless Legs Syndrome
1.3.5 Others
1.4 Gabapentin by Product Type
1.4.1 Global Gabapentin Market Value Comparison by Product Type: 2024 VS 2031
1.4.2 Branded Gabapentin
1.4.3 Generic Gabapentin
1.5 Gabapentin by Application
1.5.1 Global Gabapentin Market Value by Application (2024 VS 2031)
1.5.2 Hospital
1.5.3 Retail Pharmacy
1.6 Global Gabapentin Market Size Estimates and Forecasts
1.6.1 Global Gabapentin Revenue 2020-2031
1.6.2 Global Gabapentin Sales 2020-2031
1.6.3 Global Gabapentin Market Average Price (2020-2031)
1.7 Assumptions and Limitations
2 Gabapentin Market Competition by Manufacturers
2.1 Global Gabapentin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gabapentin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gabapentin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gabapentin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gabapentin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gabapentin, Product Type & Application
2.7 Global Key Manufacturers of Gabapentin, Date of Enter into This Industry
2.8 Global Gabapentin Market Competitive Situation and Trends
2.8.1 Global Gabapentin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gabapentin Players Market Share by Revenue
2.8.3 Global Gabapentin Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gabapentin Market Scenario by Region
3.1 Global Gabapentin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gabapentin Sales by Region: 2020-2031
3.2.1 Global Gabapentin Sales by Region: 2020-2025
3.2.2 Global Gabapentin Sales by Region: 2026-2031
3.3 Global Gabapentin Revenue by Region: 2020-2031
3.3.1 Global Gabapentin Revenue by Region: 2020-2025
3.3.2 Global Gabapentin Revenue by Region: 2026-2031
3.4 North America Gabapentin Market Facts & Figures by Country
3.4.1 North America Gabapentin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gabapentin Sales by Country (2020-2031)
3.4.3 North America Gabapentin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Gabapentin Market Facts & Figures by Country
3.5.1 Europe Gabapentin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gabapentin Sales by Country (2020-2031)
3.5.3 Europe Gabapentin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gabapentin Market Facts & Figures by Region
3.6.1 Asia Pacific Gabapentin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gabapentin Sales by Region (2020-2031)
3.6.3 Asia Pacific Gabapentin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Gabapentin Market Facts & Figures by Country
3.7.1 Latin America Gabapentin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gabapentin Sales by Country (2020-2031)
3.7.3 Latin America Gabapentin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gabapentin Market Facts & Figures by Country
3.8.1 Middle East and Africa Gabapentin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gabapentin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gabapentin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Gabapentin Sales by Type (2020-2031)
4.1.1 Global Gabapentin Sales by Type (2020-2025)
4.1.2 Global Gabapentin Sales by Type (2026-2031)
4.1.3 Global Gabapentin Sales Market Share by Type (2020-2031)
4.2 Global Gabapentin Revenue by Type (2020-2031)
4.2.1 Global Gabapentin Revenue by Type (2020-2025)
4.2.2 Global Gabapentin Revenue by Type (2026-2031)
4.2.3 Global Gabapentin Revenue Market Share by Type (2020-2031)
4.3 Global Gabapentin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gabapentin Sales by Application (2020-2031)
5.1.1 Global Gabapentin Sales by Application (2020-2025)
5.1.2 Global Gabapentin Sales by Application (2026-2031)
5.1.3 Global Gabapentin Sales Market Share by Application (2020-2031)
5.2 Global Gabapentin Revenue by Application (2020-2031)
5.2.1 Global Gabapentin Revenue by Application (2020-2025)
5.2.2 Global Gabapentin Revenue by Application (2026-2031)
5.2.3 Global Gabapentin Revenue Market Share by Application (2020-2031)
5.3 Global Gabapentin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Gabapentin Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Depomed
6.2.1 Depomed Company Information
6.2.2 Depomed Description and Business Overview
6.2.3 Depomed Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Depomed Gabapentin Product Portfolio
6.2.5 Depomed Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Company Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 TEVA Gabapentin Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Company Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Viatris Gabapentin Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 Alvogen
6.5.1 Alvogen Company Information
6.5.2 Alvogen Description and Business Overview
6.5.3 Alvogen Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Alvogen Gabapentin Product Portfolio
6.5.5 Alvogen Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Company Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novartis Gabapentin Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Apotex
6.7.1 Apotex Company Information
6.7.2 Apotex Description and Business Overview
6.7.3 Apotex Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Apotex Gabapentin Product Portfolio
6.7.5 Apotex Recent Developments/Updates
6.8 Sun Pharmaceutical
6.8.1 Sun Pharmaceutical Company Information
6.8.2 Sun Pharmaceutical Description and Business Overview
6.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sun Pharmaceutical Gabapentin Product Portfolio
6.8.5 Sun Pharmaceutical Recent Developments/Updates
6.9 Aurobindo Pharma
6.9.1 Aurobindo Pharma Company Information
6.9.2 Aurobindo Pharma Description and Business Overview
6.9.3 Aurobindo Pharma Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Aurobindo Pharma Gabapentin Product Portfolio
6.9.5 Aurobindo Pharma Recent Developments/Updates
6.10 Intas
6.10.1 Intas Company Information
6.10.2 Intas Description and Business Overview
6.10.3 Intas Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Intas Gabapentin Product Portfolio
6.10.5 Intas Recent Developments/Updates
6.11 Amneal
6.11.1 Amneal Company Information
6.11.2 Amneal Description and Business Overview
6.11.3 Amneal Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Amneal Gabapentin Product Portfolio
6.11.5 Amneal Recent Developments/Updates
6.12 Marksans Pharma
6.12.1 Marksans Pharma Company Information
6.12.2 Marksans Pharma Description and Business Overview
6.12.3 Marksans Pharma Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Marksans Pharma Gabapentin Product Portfolio
6.12.5 Marksans Pharma Recent Developments/Updates
6.13 Glenmark
6.13.1 Glenmark Company Information
6.13.2 Glenmark Description and Business Overview
6.13.3 Glenmark Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Glenmark Gabapentin Product Portfolio
6.13.5 Glenmark Recent Developments/Updates
6.14 Alkem
6.14.1 Alkem Company Information
6.14.2 Alkem Description and Business Overview
6.14.3 Alkem Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Alkem Gabapentin Product Portfolio
6.14.5 Alkem Recent Developments/Updates
6.15 Jiangsu Enhua
6.15.1 Jiangsu Enhua Company Information
6.15.2 Jiangsu Enhua Description and Business Overview
6.15.3 Jiangsu Enhua Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Jiangsu Enhua Gabapentin Product Portfolio
6.15.5 Jiangsu Enhua Recent Developments/Updates
6.16 Jiangsu Hengrui
6.16.1 Jiangsu Hengrui Company Information
6.16.2 Jiangsu Hengrui Description and Business Overview
6.16.3 Jiangsu Hengrui Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Jiangsu Hengrui Gabapentin Product Portfolio
6.16.5 Jiangsu Hengrui Recent Developments/Updates
6.17 Sailike
6.17.1 Sailike Company Information
6.17.2 Sailike Description and Business Overview
6.17.3 Sailike Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Sailike Gabapentin Product Portfolio
6.17.5 Sailike Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gabapentin Industry Chain Analysis
7.2 Gabapentin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gabapentin Production Mode & Process Analysis
7.4 Gabapentin Sales and Marketing
7.4.1 Gabapentin Sales Channels
7.4.2 Gabapentin Distributors
7.5 Gabapentin Customer Analysis
8 Gabapentin Market Dynamics
8.1 Gabapentin Industry Trends
8.2 Gabapentin Market Drivers
8.3 Gabapentin Market Challenges
8.4 Gabapentin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Gabapentin by Type
1.2.1 Global Gabapentin Market Value Comparison by Type (2024 VS 2031)
1.2.2 Capsule
1.2.3 Tablet
1.2.4 Injection
1.3 Gabapentin by Therapeutic Indication
1.3.1 Global Gabapentin Market Value Comparison by Therapeutic Indication: 2024 VS 2031
1.3.2 Epilepsy
1.3.3 Neuropathic Pain
1.3.4 Restless Legs Syndrome
1.3.5 Others
1.4 Gabapentin by Product Type
1.4.1 Global Gabapentin Market Value Comparison by Product Type: 2024 VS 2031
1.4.2 Branded Gabapentin
1.4.3 Generic Gabapentin
1.5 Gabapentin by Application
1.5.1 Global Gabapentin Market Value by Application (2024 VS 2031)
1.5.2 Hospital
1.5.3 Retail Pharmacy
1.6 Global Gabapentin Market Size Estimates and Forecasts
1.6.1 Global Gabapentin Revenue 2020-2031
1.6.2 Global Gabapentin Sales 2020-2031
1.6.3 Global Gabapentin Market Average Price (2020-2031)
1.7 Assumptions and Limitations
2 Gabapentin Market Competition by Manufacturers
2.1 Global Gabapentin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gabapentin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gabapentin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gabapentin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gabapentin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gabapentin, Product Type & Application
2.7 Global Key Manufacturers of Gabapentin, Date of Enter into This Industry
2.8 Global Gabapentin Market Competitive Situation and Trends
2.8.1 Global Gabapentin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gabapentin Players Market Share by Revenue
2.8.3 Global Gabapentin Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gabapentin Market Scenario by Region
3.1 Global Gabapentin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gabapentin Sales by Region: 2020-2031
3.2.1 Global Gabapentin Sales by Region: 2020-2025
3.2.2 Global Gabapentin Sales by Region: 2026-2031
3.3 Global Gabapentin Revenue by Region: 2020-2031
3.3.1 Global Gabapentin Revenue by Region: 2020-2025
3.3.2 Global Gabapentin Revenue by Region: 2026-2031
3.4 North America Gabapentin Market Facts & Figures by Country
3.4.1 North America Gabapentin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gabapentin Sales by Country (2020-2031)
3.4.3 North America Gabapentin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Gabapentin Market Facts & Figures by Country
3.5.1 Europe Gabapentin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gabapentin Sales by Country (2020-2031)
3.5.3 Europe Gabapentin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gabapentin Market Facts & Figures by Region
3.6.1 Asia Pacific Gabapentin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gabapentin Sales by Region (2020-2031)
3.6.3 Asia Pacific Gabapentin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Gabapentin Market Facts & Figures by Country
3.7.1 Latin America Gabapentin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gabapentin Sales by Country (2020-2031)
3.7.3 Latin America Gabapentin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gabapentin Market Facts & Figures by Country
3.8.1 Middle East and Africa Gabapentin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gabapentin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gabapentin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Gabapentin Sales by Type (2020-2031)
4.1.1 Global Gabapentin Sales by Type (2020-2025)
4.1.2 Global Gabapentin Sales by Type (2026-2031)
4.1.3 Global Gabapentin Sales Market Share by Type (2020-2031)
4.2 Global Gabapentin Revenue by Type (2020-2031)
4.2.1 Global Gabapentin Revenue by Type (2020-2025)
4.2.2 Global Gabapentin Revenue by Type (2026-2031)
4.2.3 Global Gabapentin Revenue Market Share by Type (2020-2031)
4.3 Global Gabapentin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gabapentin Sales by Application (2020-2031)
5.1.1 Global Gabapentin Sales by Application (2020-2025)
5.1.2 Global Gabapentin Sales by Application (2026-2031)
5.1.3 Global Gabapentin Sales Market Share by Application (2020-2031)
5.2 Global Gabapentin Revenue by Application (2020-2031)
5.2.1 Global Gabapentin Revenue by Application (2020-2025)
5.2.2 Global Gabapentin Revenue by Application (2026-2031)
5.2.3 Global Gabapentin Revenue Market Share by Application (2020-2031)
5.3 Global Gabapentin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Gabapentin Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Depomed
6.2.1 Depomed Company Information
6.2.2 Depomed Description and Business Overview
6.2.3 Depomed Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Depomed Gabapentin Product Portfolio
6.2.5 Depomed Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Company Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 TEVA Gabapentin Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Company Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Viatris Gabapentin Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 Alvogen
6.5.1 Alvogen Company Information
6.5.2 Alvogen Description and Business Overview
6.5.3 Alvogen Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Alvogen Gabapentin Product Portfolio
6.5.5 Alvogen Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Company Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novartis Gabapentin Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Apotex
6.7.1 Apotex Company Information
6.7.2 Apotex Description and Business Overview
6.7.3 Apotex Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Apotex Gabapentin Product Portfolio
6.7.5 Apotex Recent Developments/Updates
6.8 Sun Pharmaceutical
6.8.1 Sun Pharmaceutical Company Information
6.8.2 Sun Pharmaceutical Description and Business Overview
6.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sun Pharmaceutical Gabapentin Product Portfolio
6.8.5 Sun Pharmaceutical Recent Developments/Updates
6.9 Aurobindo Pharma
6.9.1 Aurobindo Pharma Company Information
6.9.2 Aurobindo Pharma Description and Business Overview
6.9.3 Aurobindo Pharma Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Aurobindo Pharma Gabapentin Product Portfolio
6.9.5 Aurobindo Pharma Recent Developments/Updates
6.10 Intas
6.10.1 Intas Company Information
6.10.2 Intas Description and Business Overview
6.10.3 Intas Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Intas Gabapentin Product Portfolio
6.10.5 Intas Recent Developments/Updates
6.11 Amneal
6.11.1 Amneal Company Information
6.11.2 Amneal Description and Business Overview
6.11.3 Amneal Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Amneal Gabapentin Product Portfolio
6.11.5 Amneal Recent Developments/Updates
6.12 Marksans Pharma
6.12.1 Marksans Pharma Company Information
6.12.2 Marksans Pharma Description and Business Overview
6.12.3 Marksans Pharma Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Marksans Pharma Gabapentin Product Portfolio
6.12.5 Marksans Pharma Recent Developments/Updates
6.13 Glenmark
6.13.1 Glenmark Company Information
6.13.2 Glenmark Description and Business Overview
6.13.3 Glenmark Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Glenmark Gabapentin Product Portfolio
6.13.5 Glenmark Recent Developments/Updates
6.14 Alkem
6.14.1 Alkem Company Information
6.14.2 Alkem Description and Business Overview
6.14.3 Alkem Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Alkem Gabapentin Product Portfolio
6.14.5 Alkem Recent Developments/Updates
6.15 Jiangsu Enhua
6.15.1 Jiangsu Enhua Company Information
6.15.2 Jiangsu Enhua Description and Business Overview
6.15.3 Jiangsu Enhua Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Jiangsu Enhua Gabapentin Product Portfolio
6.15.5 Jiangsu Enhua Recent Developments/Updates
6.16 Jiangsu Hengrui
6.16.1 Jiangsu Hengrui Company Information
6.16.2 Jiangsu Hengrui Description and Business Overview
6.16.3 Jiangsu Hengrui Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Jiangsu Hengrui Gabapentin Product Portfolio
6.16.5 Jiangsu Hengrui Recent Developments/Updates
6.17 Sailike
6.17.1 Sailike Company Information
6.17.2 Sailike Description and Business Overview
6.17.3 Sailike Gabapentin Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Sailike Gabapentin Product Portfolio
6.17.5 Sailike Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gabapentin Industry Chain Analysis
7.2 Gabapentin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gabapentin Production Mode & Process Analysis
7.4 Gabapentin Sales and Marketing
7.4.1 Gabapentin Sales Channels
7.4.2 Gabapentin Distributors
7.5 Gabapentin Customer Analysis
8 Gabapentin Market Dynamics
8.1 Gabapentin Industry Trends
8.2 Gabapentin Market Drivers
8.3 Gabapentin Market Challenges
8.4 Gabapentin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Gabapentin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Gabapentin Market Value by Therapeutic Indication, (US$ Million) & (2024 VS 2031)
Table 3. Global Gabapentin Market Value by Product Type, (US$ Million) & (2024 VS 2031)
Table 4. Global Gabapentin Market Value by Application (2024 VS 2031) & (US$ Million)
Table 5. Global Gabapentin Market Competitive Situation by Manufacturers in 2024
Table 6. Global Gabapentin Sales (M Units) of Key Manufacturers (2020-2025)
Table 7. Global Gabapentin Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gabapentin Revenue (US$ Million) by Manufacturers (2020-2025)
Table 9. Global Gabapentin Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market Gabapentin Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 11. Global Key Players of Gabapentin, Industry Ranking, 2022 VS 2023 VS 2024
Table 12. Global Key Manufacturers of Gabapentin, Manufacturing Sites & Headquarters
Table 13. Global Key Manufacturers of Gabapentin, Product Type & Application
Table 14. Global Key Manufacturers of Gabapentin, Date of Enter into This Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Gabapentin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin as of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Gabapentin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 19. Global Gabapentin Sales by Region (2020-2025) & (M Units)
Table 20. Global Gabapentin Sales Market Share by Region (2020-2025)
Table 21. Global Gabapentin Sales by Region (2026-2031) & (M Units)
Table 22. Global Gabapentin Sales Market Share by Region (2026-2031)
Table 23. Global Gabapentin Revenue by Region (2020-2025) & (US$ Million)
Table 24. Global Gabapentin Revenue Market Share by Region (2020-2025)
Table 25. Global Gabapentin Revenue by Region (2026-2031) & (US$ Million)
Table 26. Global Gabapentin Revenue Market Share by Region (2026-2031)
Table 27. North America Gabapentin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. North America Gabapentin Sales by Country (2020-2025) & (M Units)
Table 29. North America Gabapentin Sales by Country (2026-2031) & (M Units)
Table 30. North America Gabapentin Revenue by Country (2020-2025) & (US$ Million)
Table 31. North America Gabapentin Revenue by Country (2026-2031) & (US$ Million)
Table 32. Europe Gabapentin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 33. Europe Gabapentin Sales by Country (2020-2025) & (M Units)
Table 34. Europe Gabapentin Sales by Country (2026-2031) & (M Units)
Table 35. Europe Gabapentin Revenue by Country (2020-2025) & (US$ Million)
Table 36. Europe Gabapentin Revenue by Country (2026-2031) & (US$ Million)
Table 37. Asia Pacific Gabapentin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 38. Asia Pacific Gabapentin Sales by Region (2020-2025) & (M Units)
Table 39. Asia Pacific Gabapentin Sales by Region (2026-2031) & (M Units)
Table 40. Asia Pacific Gabapentin Revenue by Region (2020-2025) & (US$ Million)
Table 41. Asia Pacific Gabapentin Revenue by Region (2026-2031) & (US$ Million)
Table 42. Latin America Gabapentin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Latin America Gabapentin Sales by Country (2020-2025) & (M Units)
Table 44. Latin America Gabapentin Sales by Country (2026-2031) & (M Units)
Table 45. Latin America Gabapentin Revenue by Country (2020-2025) & (US$ Million)
Table 46. Latin America Gabapentin Revenue by Country (2026-2031) & (US$ Million)
Table 47. Middle East and Africa Gabapentin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 48. Middle East and Africa Gabapentin Sales by Country (2020-2025) & (M Units)
Table 49. Middle East and Africa Gabapentin Sales by Country (2026-2031) & (M Units)
Table 50. Middle East and Africa Gabapentin Revenue by Country (2020-2025) & (US$ Million)
Table 51. Middle East and Africa Gabapentin Revenue by Country (2026-2031) & (US$ Million)
Table 52. Global Gabapentin Sales (M Units) by Type (2020-2025)
Table 53. Global Gabapentin Sales (M Units) by Type (2026-2031)
Table 54. Global Gabapentin Sales Market Share by Type (2020-2025)
Table 55. Global Gabapentin Sales Market Share by Type (2026-2031)
Table 56. Global Gabapentin Revenue (US$ Million) by Type (2020-2025)
Table 57. Global Gabapentin Revenue (US$ Million) by Type (2026-2031)
Table 58. Global Gabapentin Revenue Market Share by Type (2020-2025)
Table 59. Global Gabapentin Revenue Market Share by Type (2026-2031)
Table 60. Global Gabapentin Price (US$/Unit) by Type (2020-2025)
Table 61. Global Gabapentin Price (US$/Unit) by Type (2026-2031)
Table 62. Global Gabapentin Sales (M Units) by Application (2020-2025)
Table 63. Global Gabapentin Sales (M Units) by Application (2026-2031)
Table 64. Global Gabapentin Sales Market Share by Application (2020-2025)
Table 65. Global Gabapentin Sales Market Share by Application (2026-2031)
Table 66. Global Gabapentin Revenue (US$ Million) by Application (2020-2025)
Table 67. Global Gabapentin Revenue (US$ Million) by Application (2026-2031)
Table 68. Global Gabapentin Revenue Market Share by Application (2020-2025)
Table 69. Global Gabapentin Revenue Market Share by Application (2026-2031)
Table 70. Global Gabapentin Price (US$/Unit) by Application (2020-2025)
Table 71. Global Gabapentin Price (US$/Unit) by Application (2026-2031)
Table 72. Pfizer Company Information
Table 73. Pfizer Description and Business Overview
Table 74. Pfizer Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Pfizer Gabapentin Product
Table 76. Pfizer Recent Developments/Updates
Table 77. Depomed Company Information
Table 78. Depomed Description and Business Overview
Table 79. Depomed Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Depomed Gabapentin Product
Table 81. Depomed Recent Developments/Updates
Table 82. TEVA Company Information
Table 83. TEVA Description and Business Overview
Table 84. TEVA Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. TEVA Gabapentin Product
Table 86. TEVA Recent Developments/Updates
Table 87. Viatris Company Information
Table 88. Viatris Description and Business Overview
Table 89. Viatris Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Viatris Gabapentin Product
Table 91. Viatris Recent Developments/Updates
Table 92. Alvogen Company Information
Table 93. Alvogen Description and Business Overview
Table 94. Alvogen Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Alvogen Gabapentin Product
Table 96. Alvogen Recent Developments/Updates
Table 97. Novartis Company Information
Table 98. Novartis Description and Business Overview
Table 99. Novartis Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Novartis Gabapentin Product
Table 101. Novartis Recent Developments/Updates
Table 102. Apotex Company Information
Table 103. Apotex Description and Business Overview
Table 104. Apotex Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Apotex Gabapentin Product
Table 106. Apotex Recent Developments/Updates
Table 107. Sun Pharmaceutical Company Information
Table 108. Sun Pharmaceutical Description and Business Overview
Table 109. Sun Pharmaceutical Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Sun Pharmaceutical Gabapentin Product
Table 111. Sun Pharmaceutical Recent Developments/Updates
Table 112. Aurobindo Pharma Company Information
Table 113. Aurobindo Pharma Description and Business Overview
Table 114. Aurobindo Pharma Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Aurobindo Pharma Gabapentin Product
Table 116. Aurobindo Pharma Recent Developments/Updates
Table 117. Intas Company Information
Table 118. Intas Description and Business Overview
Table 119. Intas Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Intas Gabapentin Product
Table 121. Intas Recent Developments/Updates
Table 122. Amneal Company Information
Table 123. Amneal Description and Business Overview
Table 124. Amneal Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Amneal Gabapentin Product
Table 126. Amneal Recent Developments/Updates
Table 127. Marksans Pharma Company Information
Table 128. Marksans Pharma Description and Business Overview
Table 129. Marksans Pharma Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Marksans Pharma Gabapentin Product
Table 131. Marksans Pharma Recent Developments/Updates
Table 132. Glenmark Company Information
Table 133. Glenmark Description and Business Overview
Table 134. Glenmark Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. Glenmark Gabapentin Product
Table 136. Glenmark Recent Developments/Updates
Table 137. Alkem Company Information
Table 138. Alkem Description and Business Overview
Table 139. Alkem Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 140. Alkem Gabapentin Product
Table 141. Alkem Recent Developments/Updates
Table 142. Jiangsu Enhua Company Information
Table 143. Jiangsu Enhua Description and Business Overview
Table 144. Jiangsu Enhua Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 145. Jiangsu Enhua Gabapentin Product
Table 146. Jiangsu Enhua Recent Developments/Updates
Table 147. Jiangsu Hengrui Company Information
Table 148. Jiangsu Hengrui Description and Business Overview
Table 149. Jiangsu Hengrui Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 150. Jiangsu Hengrui Gabapentin Product
Table 151. Jiangsu Hengrui Recent Developments/Updates
Table 152. Sailike Company Information
Table 153. Sailike Description and Business Overview
Table 154. Sailike Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 155. Sailike Gabapentin Product
Table 156. Sailike Recent Developments/Updates
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Gabapentin Distributors List
Table 160. Gabapentin Customers List
Table 161. Gabapentin Market Trends
Table 162. Gabapentin Market Drivers
Table 163. Gabapentin Market Challenges
Table 164. Gabapentin Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
Table 168. Authors List of This Report
List of Figures
Figure 1. Product Picture of Gabapentin
Figure 2. Global Gabapentin Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gabapentin Market Share by Type: 2024 & 2031
Figure 4. Capsule Product Picture
Figure 5. Tablet Product Picture
Figure 6. Injection Product Picture
Figure 7. Global Gabapentin Market Value by Therapeutic Indication, (US$ Million) & (2020-2031)
Figure 8. Global Gabapentin Market Share by Therapeutic Indication: 2024 VS 2031
Figure 9. Epilepsy Product Picture
Figure 10. Neuropathic Pain Product Picture
Figure 11. Restless Legs Syndrome Product Picture
Figure 12. Others Product Picture
Figure 13. Global Gabapentin Market Value by Product Type, (US$ Million) & (2020-2031)
Figure 14. Global Gabapentin Market Share by Product Type: 2024 VS 2031
Figure 15. Branded Gabapentin Product Picture
Figure 16. Generic Gabapentin Product Picture
Figure 17. Global Gabapentin Market Value by Application (2020-2031) & (US$ Million)
Figure 18. Global Gabapentin Market Share by Application: 2024 & 2031
Figure 19. Hospital
Figure 20. Retail Pharmacy
Figure 21. Global Gabapentin Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 22. Global Gabapentin Market Size (2020-2031) & (US$ Million)
Figure 23. Global Gabapentin Sales (2020-2031) & (M Units)
Figure 24. Global Gabapentin Average Price (US$/Unit) & (2020-2031)
Figure 25. Gabapentin Report Years Considered
Figure 26. Gabapentin Sales Share by Manufacturers in 2024
Figure 27. Global Gabapentin Revenue Share by Manufacturers in 2024
Figure 28. Global 5 and 10 Largest Gabapentin Players: Market Share by Revenue in Gabapentin in 2024
Figure 29. Gabapentin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 30. Global Gabapentin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 31. North America Gabapentin Sales Market Share by Country (2020-2031)
Figure 32. North America Gabapentin Revenue Market Share by Country (2020-2031)
Figure 33. U.S. Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Canada Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Europe Gabapentin Sales Market Share by Country (2020-2031)
Figure 36. Europe Gabapentin Revenue Market Share by Country (2020-2031)
Figure 37. Germany Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. France Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. U.K. Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Italy Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Russia Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Asia Pacific Gabapentin Sales Market Share by Region (2020-2031)
Figure 43. Asia Pacific Gabapentin Revenue Market Share by Region (2020-2031)
Figure 44. China Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Japan Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. South Korea Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. India Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Australia Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Taiwan Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Indonesia Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Thailand Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Malaysia Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Philippines Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Latin America Gabapentin Sales Market Share by Country (2020-2031)
Figure 55. Latin America Gabapentin Revenue Market Share by Country (2020-2031)
Figure 56. Mexico Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Brazil Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Argentina Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Middle East and Africa Gabapentin Sales Market Share by Country (2020-2031)
Figure 60. Middle East and Africa Gabapentin Revenue Market Share by Country (2020-2031)
Figure 61. Turkey Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 62. Saudi Arabia Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 63. U.A.E Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 64. Global Sales Market Share of Gabapentin by Type (2020-2031)
Figure 65. Global Revenue Market Share of Gabapentin by Type (2020-2031)
Figure 66. Global Gabapentin Price (US$/Unit) by Type (2020-2031)
Figure 67. Global Sales Market Share of Gabapentin by Application (2020-2031)
Figure 68. Global Revenue Market Share of Gabapentin by Application (2020-2031)
Figure 69. Global Gabapentin Price (US$/Unit) by Application (2020-2031)
Figure 70. Gabapentin Value Chain
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Table 1. Global Gabapentin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Gabapentin Market Value by Therapeutic Indication, (US$ Million) & (2024 VS 2031)
Table 3. Global Gabapentin Market Value by Product Type, (US$ Million) & (2024 VS 2031)
Table 4. Global Gabapentin Market Value by Application (2024 VS 2031) & (US$ Million)
Table 5. Global Gabapentin Market Competitive Situation by Manufacturers in 2024
Table 6. Global Gabapentin Sales (M Units) of Key Manufacturers (2020-2025)
Table 7. Global Gabapentin Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gabapentin Revenue (US$ Million) by Manufacturers (2020-2025)
Table 9. Global Gabapentin Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market Gabapentin Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 11. Global Key Players of Gabapentin, Industry Ranking, 2022 VS 2023 VS 2024
Table 12. Global Key Manufacturers of Gabapentin, Manufacturing Sites & Headquarters
Table 13. Global Key Manufacturers of Gabapentin, Product Type & Application
Table 14. Global Key Manufacturers of Gabapentin, Date of Enter into This Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Gabapentin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin as of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Gabapentin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 19. Global Gabapentin Sales by Region (2020-2025) & (M Units)
Table 20. Global Gabapentin Sales Market Share by Region (2020-2025)
Table 21. Global Gabapentin Sales by Region (2026-2031) & (M Units)
Table 22. Global Gabapentin Sales Market Share by Region (2026-2031)
Table 23. Global Gabapentin Revenue by Region (2020-2025) & (US$ Million)
Table 24. Global Gabapentin Revenue Market Share by Region (2020-2025)
Table 25. Global Gabapentin Revenue by Region (2026-2031) & (US$ Million)
Table 26. Global Gabapentin Revenue Market Share by Region (2026-2031)
Table 27. North America Gabapentin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. North America Gabapentin Sales by Country (2020-2025) & (M Units)
Table 29. North America Gabapentin Sales by Country (2026-2031) & (M Units)
Table 30. North America Gabapentin Revenue by Country (2020-2025) & (US$ Million)
Table 31. North America Gabapentin Revenue by Country (2026-2031) & (US$ Million)
Table 32. Europe Gabapentin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 33. Europe Gabapentin Sales by Country (2020-2025) & (M Units)
Table 34. Europe Gabapentin Sales by Country (2026-2031) & (M Units)
Table 35. Europe Gabapentin Revenue by Country (2020-2025) & (US$ Million)
Table 36. Europe Gabapentin Revenue by Country (2026-2031) & (US$ Million)
Table 37. Asia Pacific Gabapentin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 38. Asia Pacific Gabapentin Sales by Region (2020-2025) & (M Units)
Table 39. Asia Pacific Gabapentin Sales by Region (2026-2031) & (M Units)
Table 40. Asia Pacific Gabapentin Revenue by Region (2020-2025) & (US$ Million)
Table 41. Asia Pacific Gabapentin Revenue by Region (2026-2031) & (US$ Million)
Table 42. Latin America Gabapentin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Latin America Gabapentin Sales by Country (2020-2025) & (M Units)
Table 44. Latin America Gabapentin Sales by Country (2026-2031) & (M Units)
Table 45. Latin America Gabapentin Revenue by Country (2020-2025) & (US$ Million)
Table 46. Latin America Gabapentin Revenue by Country (2026-2031) & (US$ Million)
Table 47. Middle East and Africa Gabapentin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 48. Middle East and Africa Gabapentin Sales by Country (2020-2025) & (M Units)
Table 49. Middle East and Africa Gabapentin Sales by Country (2026-2031) & (M Units)
Table 50. Middle East and Africa Gabapentin Revenue by Country (2020-2025) & (US$ Million)
Table 51. Middle East and Africa Gabapentin Revenue by Country (2026-2031) & (US$ Million)
Table 52. Global Gabapentin Sales (M Units) by Type (2020-2025)
Table 53. Global Gabapentin Sales (M Units) by Type (2026-2031)
Table 54. Global Gabapentin Sales Market Share by Type (2020-2025)
Table 55. Global Gabapentin Sales Market Share by Type (2026-2031)
Table 56. Global Gabapentin Revenue (US$ Million) by Type (2020-2025)
Table 57. Global Gabapentin Revenue (US$ Million) by Type (2026-2031)
Table 58. Global Gabapentin Revenue Market Share by Type (2020-2025)
Table 59. Global Gabapentin Revenue Market Share by Type (2026-2031)
Table 60. Global Gabapentin Price (US$/Unit) by Type (2020-2025)
Table 61. Global Gabapentin Price (US$/Unit) by Type (2026-2031)
Table 62. Global Gabapentin Sales (M Units) by Application (2020-2025)
Table 63. Global Gabapentin Sales (M Units) by Application (2026-2031)
Table 64. Global Gabapentin Sales Market Share by Application (2020-2025)
Table 65. Global Gabapentin Sales Market Share by Application (2026-2031)
Table 66. Global Gabapentin Revenue (US$ Million) by Application (2020-2025)
Table 67. Global Gabapentin Revenue (US$ Million) by Application (2026-2031)
Table 68. Global Gabapentin Revenue Market Share by Application (2020-2025)
Table 69. Global Gabapentin Revenue Market Share by Application (2026-2031)
Table 70. Global Gabapentin Price (US$/Unit) by Application (2020-2025)
Table 71. Global Gabapentin Price (US$/Unit) by Application (2026-2031)
Table 72. Pfizer Company Information
Table 73. Pfizer Description and Business Overview
Table 74. Pfizer Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Pfizer Gabapentin Product
Table 76. Pfizer Recent Developments/Updates
Table 77. Depomed Company Information
Table 78. Depomed Description and Business Overview
Table 79. Depomed Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Depomed Gabapentin Product
Table 81. Depomed Recent Developments/Updates
Table 82. TEVA Company Information
Table 83. TEVA Description and Business Overview
Table 84. TEVA Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. TEVA Gabapentin Product
Table 86. TEVA Recent Developments/Updates
Table 87. Viatris Company Information
Table 88. Viatris Description and Business Overview
Table 89. Viatris Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Viatris Gabapentin Product
Table 91. Viatris Recent Developments/Updates
Table 92. Alvogen Company Information
Table 93. Alvogen Description and Business Overview
Table 94. Alvogen Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Alvogen Gabapentin Product
Table 96. Alvogen Recent Developments/Updates
Table 97. Novartis Company Information
Table 98. Novartis Description and Business Overview
Table 99. Novartis Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Novartis Gabapentin Product
Table 101. Novartis Recent Developments/Updates
Table 102. Apotex Company Information
Table 103. Apotex Description and Business Overview
Table 104. Apotex Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Apotex Gabapentin Product
Table 106. Apotex Recent Developments/Updates
Table 107. Sun Pharmaceutical Company Information
Table 108. Sun Pharmaceutical Description and Business Overview
Table 109. Sun Pharmaceutical Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Sun Pharmaceutical Gabapentin Product
Table 111. Sun Pharmaceutical Recent Developments/Updates
Table 112. Aurobindo Pharma Company Information
Table 113. Aurobindo Pharma Description and Business Overview
Table 114. Aurobindo Pharma Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Aurobindo Pharma Gabapentin Product
Table 116. Aurobindo Pharma Recent Developments/Updates
Table 117. Intas Company Information
Table 118. Intas Description and Business Overview
Table 119. Intas Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Intas Gabapentin Product
Table 121. Intas Recent Developments/Updates
Table 122. Amneal Company Information
Table 123. Amneal Description and Business Overview
Table 124. Amneal Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Amneal Gabapentin Product
Table 126. Amneal Recent Developments/Updates
Table 127. Marksans Pharma Company Information
Table 128. Marksans Pharma Description and Business Overview
Table 129. Marksans Pharma Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Marksans Pharma Gabapentin Product
Table 131. Marksans Pharma Recent Developments/Updates
Table 132. Glenmark Company Information
Table 133. Glenmark Description and Business Overview
Table 134. Glenmark Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. Glenmark Gabapentin Product
Table 136. Glenmark Recent Developments/Updates
Table 137. Alkem Company Information
Table 138. Alkem Description and Business Overview
Table 139. Alkem Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 140. Alkem Gabapentin Product
Table 141. Alkem Recent Developments/Updates
Table 142. Jiangsu Enhua Company Information
Table 143. Jiangsu Enhua Description and Business Overview
Table 144. Jiangsu Enhua Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 145. Jiangsu Enhua Gabapentin Product
Table 146. Jiangsu Enhua Recent Developments/Updates
Table 147. Jiangsu Hengrui Company Information
Table 148. Jiangsu Hengrui Description and Business Overview
Table 149. Jiangsu Hengrui Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 150. Jiangsu Hengrui Gabapentin Product
Table 151. Jiangsu Hengrui Recent Developments/Updates
Table 152. Sailike Company Information
Table 153. Sailike Description and Business Overview
Table 154. Sailike Gabapentin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 155. Sailike Gabapentin Product
Table 156. Sailike Recent Developments/Updates
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Gabapentin Distributors List
Table 160. Gabapentin Customers List
Table 161. Gabapentin Market Trends
Table 162. Gabapentin Market Drivers
Table 163. Gabapentin Market Challenges
Table 164. Gabapentin Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
Table 168. Authors List of This Report
List of Figures
Figure 1. Product Picture of Gabapentin
Figure 2. Global Gabapentin Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gabapentin Market Share by Type: 2024 & 2031
Figure 4. Capsule Product Picture
Figure 5. Tablet Product Picture
Figure 6. Injection Product Picture
Figure 7. Global Gabapentin Market Value by Therapeutic Indication, (US$ Million) & (2020-2031)
Figure 8. Global Gabapentin Market Share by Therapeutic Indication: 2024 VS 2031
Figure 9. Epilepsy Product Picture
Figure 10. Neuropathic Pain Product Picture
Figure 11. Restless Legs Syndrome Product Picture
Figure 12. Others Product Picture
Figure 13. Global Gabapentin Market Value by Product Type, (US$ Million) & (2020-2031)
Figure 14. Global Gabapentin Market Share by Product Type: 2024 VS 2031
Figure 15. Branded Gabapentin Product Picture
Figure 16. Generic Gabapentin Product Picture
Figure 17. Global Gabapentin Market Value by Application (2020-2031) & (US$ Million)
Figure 18. Global Gabapentin Market Share by Application: 2024 & 2031
Figure 19. Hospital
Figure 20. Retail Pharmacy
Figure 21. Global Gabapentin Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 22. Global Gabapentin Market Size (2020-2031) & (US$ Million)
Figure 23. Global Gabapentin Sales (2020-2031) & (M Units)
Figure 24. Global Gabapentin Average Price (US$/Unit) & (2020-2031)
Figure 25. Gabapentin Report Years Considered
Figure 26. Gabapentin Sales Share by Manufacturers in 2024
Figure 27. Global Gabapentin Revenue Share by Manufacturers in 2024
Figure 28. Global 5 and 10 Largest Gabapentin Players: Market Share by Revenue in Gabapentin in 2024
Figure 29. Gabapentin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 30. Global Gabapentin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 31. North America Gabapentin Sales Market Share by Country (2020-2031)
Figure 32. North America Gabapentin Revenue Market Share by Country (2020-2031)
Figure 33. U.S. Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Canada Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Europe Gabapentin Sales Market Share by Country (2020-2031)
Figure 36. Europe Gabapentin Revenue Market Share by Country (2020-2031)
Figure 37. Germany Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. France Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. U.K. Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Italy Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Russia Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Asia Pacific Gabapentin Sales Market Share by Region (2020-2031)
Figure 43. Asia Pacific Gabapentin Revenue Market Share by Region (2020-2031)
Figure 44. China Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Japan Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. South Korea Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. India Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Australia Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Taiwan Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Indonesia Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Thailand Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Malaysia Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Philippines Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Latin America Gabapentin Sales Market Share by Country (2020-2031)
Figure 55. Latin America Gabapentin Revenue Market Share by Country (2020-2031)
Figure 56. Mexico Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Brazil Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Argentina Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Middle East and Africa Gabapentin Sales Market Share by Country (2020-2031)
Figure 60. Middle East and Africa Gabapentin Revenue Market Share by Country (2020-2031)
Figure 61. Turkey Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 62. Saudi Arabia Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 63. U.A.E Gabapentin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 64. Global Sales Market Share of Gabapentin by Type (2020-2031)
Figure 65. Global Revenue Market Share of Gabapentin by Type (2020-2031)
Figure 66. Global Gabapentin Price (US$/Unit) by Type (2020-2031)
Figure 67. Global Sales Market Share of Gabapentin by Application (2020-2031)
Figure 68. Global Revenue Market Share of Gabapentin by Application (2020-2031)
Figure 69. Global Gabapentin Price (US$/Unit) by Application (2020-2031)
Figure 70. Gabapentin Value Chain
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232